Studies showed LDHA and LDHB both function redundantly in cancer, so targeting both would be more advantageous for therapeutic purposes [155], In melanoma, cas9-mediated deletion of both isoenzymes showed favorable effects on tumor mass shrinkage. This evidence concerns the gene LDHA and neoplasm.